Country | Clinical service | Indicator | N | KP mapping & size estimation | KP empowerment | Structural interventions | Peer outreach | Clinical services | Program management | Monitoring & data use | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | UC | 95% CI | UC | 95% CI | UC | 95% CI | UC | 95% CI | UC | 95% CI | UC | 95% CI | UC | 95% CI |
Kenya | PEP | Treated | 25 | 19 | 16–23 | 25 | 21–30 | 22 | 18–25 | 107 | 89–125 | 102 | 85–119 | 118 | 98–138 | 62 | 52–73 |
PREP | On PrEPa | 30 | 28 | 22–35 | 36 | 27–45 | 31 | 23–38 | 127 | 97–157 | 161 | 122–199 | 167 | 127–206 | 85 | 65–105 | |
HTS | Tested | 30 | 1 | 1–1 | 1 | 1–1 | 1 | 1–1 | 3 | 3–3 | 9 | 8–11 | 6 | 5–6 | 3 | 2–3 | |
ART | On ARTa | 30 | 11 | 9–13 | 14 | 11–17 | 12 | 10–14 | 31 | 25–37 | 201 | 163–239 | 66 | 53–78 | 34 | 27–40 | |
STI | Screened | 30 | 1 | 1–1 | 1 | 1–1 | 1 | 1–1 | 2 | 2–2 | 6 | 6–7 | 5 | 4–5 | 2 | 2–3 | |
SRH | Provided CM | 23 | 4 | 4–5 | 5 | 5–6 | 5 | 4–5 | 20 | 17–22 | 21 | 18–23 | 26 | 23–29 | 14 | 12–16 | |
MSV | Provided post-GBV care | 29 | 4 | 3–5 | 5 | 4–7 | 5 | 4–6 | 20 | 15–25 | 18 | 14–22 | 25 | 19–31 | 13 | 10–16 | |
Malawi | HTS | Tested | 15 | 5 | 5–6 | 5 | 4–5 | 3 | 3–4 | 13 | 12–15 | 27 | 24–31 | 19 | 16–21 | 11 | 10–13 |
ART | On ARTa | 15 | 48 | 39–58 | 42 | 34–51 | 28 | 22–33 | 118 | 95–142 | 258 | 207–309 | 164 | 132–197 | 99 | 80–119 | |
STI | Screened | 15 | 3 | 3–3 | 3 | 2–3 | 2 | 2–2 | 6 | 6–7 | 11 | 10–12 | 10 | 9–11 | 6 | 6–7 | |
SRH | Provided CM | 11 | 7 | 7–8 | 6 | 5–7 | 4 | 3–4 | 20 | 17–22 | 32 | 28–36 | 22 | 19–24 | 17 | 14–19 | |
MSV | Provided post-GBV care | 15 | 86 | 81–92 | 75 | 70–81 | 49 | 46–52 | 261 | 243–279 | 298 | 278–318 | 291 | 271–310 | 179 | 167–192 |